Manfred Groeppel - Net Worth and Insider Trading

Manfred Groeppel Net Worth

The estimated net worth of Manfred Groeppel is at least $356,902 dollars as of 2024-05-01. Manfred Groeppel is the COO of Immunic Inc and owns about 278,830 shares of Immunic Inc (IMUX) stock worth over $356,902. Details can be seen in Manfred Groeppel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Manfred Groeppel has not made any transactions after 2020-07-21 and currently still holds the listed stock(s).

Transaction Summary of Manfred Groeppel

To

Manfred Groeppel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Manfred Groeppel owns 1 companies in total, including Immunic Inc (IMUX) .

Click here to see the complete history of Manfred Groeppel’s form 4 insider trades.

Insider Ownership Summary of Manfred Groeppel

Ticker Comapny Transaction Date Type of Owner
IMUX Immunic Inc 2020-07-21 Chief Operating Officer

Manfred Groeppel Latest Holdings Summary

Manfred Groeppel currently owns a total of 1 stock. Manfred Groeppel owns 278,830 shares of Immunic Inc (IMUX) as of July 21, 2020, with a value of $356,902.

Latest Holdings of Manfred Groeppel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMUX Immunic Inc 2020-07-21 278,830 1.28 356,902

Holding Weightings of Manfred Groeppel


Manfred Groeppel Form 4 Trading Tracker

According to the SEC Form 4 filings, Manfred Groeppel has made a total of 1 transactions in Immunic Inc (IMUX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Immunic Inc is the sale of 5,650 shares on July 21, 2020, which brought Manfred Groeppel around $82,377.

Insider Trading History of Manfred Groeppel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Manfred Groeppel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Manfred Groeppel Ownership Network

Ownership Network List of Manfred Groeppel

No Data

Ownership Network Relation of Manfred Groeppel


Manfred Groeppel Owned Company Details

What does Immunic Inc do?

Who are the key executives at Immunic Inc?

Manfred Groeppel is the Chief Operating Officer of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .

Immunic Inc (IMUX) Insider Trades Summary

Over the past 18 months, Manfred Groeppel made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 100,000 shares made by Joerg Neermann , a net purchase of 22,000 shares made by Daniel Vitt , and a net purchase of 10,000 shares made by Glenn Whaley .

In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 14,000 shares, with a net purchase of 14,000 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 132,000 shares were bought by its insiders, resulting in a net purchase of 132,000 shares.

Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunic Inc Insider Transactions

No Available Data

Manfred Groeppel Mailing Address

Above is the net worth, insider trading, and ownership report for Manfred Groeppel. You might contact Manfred Groeppel via mailing address: Immunic Ag, Am Klopferspitz 19, Martinsried 2m 82152.

Discussions on Manfred Groeppel

No discussions yet.